April 28, 2016 to May 1, 2016
Sheraton New Orleans Hotel, New Orleans, Louisiana
Sanja Dacic, M.D.
Dr. Sanja Dacic is a thoracic surgical pathologist, Director of the FISH and Developmental Laboratory and Professor of Pathology at the University of Pittsburgh Medical Center. Her primary research interests relate to molecular profiling of lung carcinoma and mesotheliomas and detection of biomarkers that have a potential to be used clinically for diagnosis, prognostication and treatment of lung carcinoma and mesothelioma. She joined the USCAP as a pathologist-in-training in 1998 and since then she has regularly presented her research either as posters or platform presentations at the USCAP annual meetings. She was a co-director of three short courses in thoracic pathology that were presented at the USCAP Annual Meetings (2006-2009; 2010-2012 and 2013-2015) and she was an invited speaker at the Pulmonary Pathology Society Companion Meeting in 2010. She has been a member of the USCAP Education Committee from 2011-2015 and a member of the Unique Live Course Offerings Subcommittee from 2013-2015. She is a moderator for the Pulmonary Pathology Specialty Conference since 2014 and will serve until 2016. Dr. Dacic was elected to the Board of Directors of USCAP in 2015. She is also a member of the pathology committee for the International Association for the Study of Lung Cancer (IASLC) and a member of the International Mesothelioma Panel. She serves as a Deputy Chief Editor of the Archives of Pathology and Laboratory Medicine.
Andrew L. Folpe, M.D.
Dr. Folpe is Professor and Consultant at the Division of Anatomic Pathology, Mayo Clinic, Rochester, MN. He attended Amherst College (Amherst, MA) as an undergraduate, the University of Rochester (Rochester, NY) as a medical student, and completed his residency in Anatomic Pathology at the University of Washington Medical Center (Seattle, WA). Dr. Folpe received additional fellowship training in immunohistochemistry, under the direction of Dr. Allen Gown, and in soft tissue pathology, under the direction of Dr. Sharon Weiss. He is the author of more than 170 medical publications, principally in the areas of soft tissue pathology and diagnostic immunohistochemistry, the co-author of the 6th edition of Enzinger and Weiss’ Soft Tissue Tumors and the most recent Armed Forces Institute of Pathology Fascicle on Soft Tissue Tumors, the co-author of Bone and Soft Tissue Pathology: A Volume in the Foundations in Diagnostic Pathology Series, and a member of the consensus conferences for the 3rd and 4th editions of the WHO Classification of Tumors of Soft Tissue and Bone. Dr. Folpe also serves on the editorial boards of numerous pathology and dermatopathology journals and has lectured widely on various aspects of soft tissue pathology and diagnostic immunohistochemistry. In his discretionary time, he enjoys spending time with his family, and is an avid cyclist, hiker of Australian Shepherds, and chef.
Andrew Horvai, M.D., Ph.D.
Dr. Horvai completed his undergraduate studies in Biology at UCLA in 1990 and received M.D. and Ph.D. degrees from UCSD. His Ph.D. thesis focused on the control of gene expression in macrophages, in particular, the foam cells of atherosclerotic plaques, in the laboratory of Dr. Christopher Glass. He completed an internship in General Surgery at UCSF and residency and fellowship training in Pathology at UCSF, finishing his training in 2003. He joined the pathology faculty at UCSF in 2003 where he has served as Medical Director of Histology and is currently an Associate Director of Surgical Pathology. He specializes in Bone and Soft Tissue pathology. He has authored more than 60 articles, reviews and book chapters, is the editor of Bone and Soft Tissue Pathology, a volume in the High-Yield Pathology series and the author of the Bone and Soft Tissue chapter in the most recent (9th edition) Robbins Pathologic Basis of Disease. Dr. Horvai is also an avid cyclist and rides competitively in road and cyclocross events.
Jennifer Hunt, M.D.
Dr. Jennifer Hunt is the Chair of Pathology at the University of Arkansas for Medical Sciences, where she holds the Aubrey J. Hough Endowed Professorship. Dr. Hunt was an undergraduate at Bryn Mawr College and then pursued her Masters of Education and Medical Degree at the University of Pennsylvania. She has held prior academic appointments at the University of Pittsburgh, the Cleveland Clinic, and Harvard Medical School. She has served on numerous committees with the College of American Pathologists, including the Curriculum Committee, Council on Membership and Professional Development, and the Publications committee, and has been an active member of the United States and Canadian Association for Pathology, including past service on the Education Committee and as an elected member of the Board. She was elected into several leadership positions in the Association for Molecular Pathology, including most recently as the President of the organization in 2013. In 2014, Dr. Hunt was elected as a member of the Board of Governors of the College of American Pathologists and is currently serving in her first term. She has received awards for leadership, scientific contributions, and teaching, including the Lansky Award, the Arthur Purdy Stout Award, and the CAP Award for Excellence in Teaching. Dr. Hunt has authored more than 150 publications in endocrine, head & neck, molecular pathology and quality assurance. Her research has focused on the study of tumor-associated genetic alterations and mutations in neoplasia, with a strong emphasis on translational applications to improve and expand molecular diagnostic testing for understanding tumor pathogenesis, prognosis, and improved diagnostics.
Sanjay Kakar, M.D.
Sanjay Kakar, MD, is Professor of Pathology, Chief of the GI-liver pathology service, and GI-liver pathology fellowship director at University of California San Francisco. After completing medical school training in India, he attended the University of Illinois in Chicago for pathology residency followed by GI-liver and molecular pathology fellowships at Mayo Clinic, Rochester, MN. He is past president of United States Gastrointestinal Pathology Society, has served on the CAP Surgical Pathology Committee and is currently a member of the CAP Cancer Committee and AJCC staging panel for colorectal and hepatobiliary cancers. His principal research interests are focused on hepatocellular adenoma, hepatocellular carcinoma and colorectal cancer.
Jesse McKenney, M.D.
Dr. Jesse McKenney is a native Texan from the Dallas/Fort-Worth area. He attended Texas A&M University where he studied learning theory and cognitive psychology. He subsequently attended the University of Texas Southwestern Medical School at Dallas, where he also began his pathology career as a post-sophomore fellow. He completed his anatomic pathology residency at Emory University in Atlanta, GA and gained subspecialty training in genitourinary and soft tissue pathology. He next completed a surgical pathology fellowship at Stanford University, where he focused on gynecologic pathology. Dr. McKenney has held faculty positions at the University of Arkansas and Stanford University, and is now the Director of Surgical Pathology at the Cleveland Clinic where he practices genitourinary, soft tissue, and gynecologic pathology. He served on the Education Committee of the USCAP for 8 years, and is a current member of the WHO and AJCC committees for the classification and staging of genitourinary neoplasia. He has authored or co-authored more than 100 manuscripts and will be co-editor of the 11th edition of Rosai and Ackerman’s Surgical Pathology.
Michael Torbenson, M.D.
Dr. Torbenson is a Professor of Pathology at Mayo Clinic, Rochester, Minnesota, MN, where he specializes in GI and liver Pathology. He has authored more than 200 papers, numerous book chapters, and two recent books on liver pathology, including a book on liver biopsy interpretation and a book on tumors of the liver. Dr. Torbenson grew up in Minnesota, but trained at the University of Pittsburgh Medical Center for residency and for a fellowship in liver and transplant pathology, followed by a GI pathology fellowship at Johns Hopkins where he remained on faculty until 2013, when he returned to Minnesota and joined the Mayo Clinic Rochester.
Ilan Weinreb, M.D.
Dr. Weinreb graduated from the University of Toronto, Faculty of Medicine in 2001 and after a short stint in General Surgery residency made a switch to Pathology where he graduated in 2006. After a head and neck fellowship in Toronto he began his academic position in 2007 at the University Health Network. He works in an exclusive head and neck subspecialty service and is the director of the Head and Neck Pathology fellowship program. Dr. Weinreb has presented at numerous national and international meetings as an invited speaker and in short courses in the College of American Pathologists, Canadian Association of Pathologists and the United States and Canadian Academy of Pathologists (USCAP). He has been involved in numerous committees including at the USCAP and has served on the education committee. He has published more than 80 peer-reviewed manuscripts, multiple book chapters and is involved in the WHO classification of head and neck tumors. His research is focused on head and neck mucosal disease, sinonasal neoplasms, and in particular, salivary gland pathology. In the salivary gland he has discovered numerous tumor-specific translocations and mutations and has a specific interest in salivary gland tumor classification.